Stroke Studies

If you think you may qualify for one of these studies, please contact CNI’s Research Department at 303-806-7423.

Outpatient

BCI-FES: Brain Computer Interface-Functional Electrical Stimulation System for Upper-Limb Rehabilitation Therapy with Stroke Patients

This study focuses on subjects, 21 years or age or older, who have a paralyzed or weakened arm due to stroke.  The study explores the potential to use electrical brain signals and electrical stimulation feedback to promote upper limb rehabilitation.  Subjects will be asked to attend 25 sessions of approximately 1 hour each, over the course of 8 weeks.

Open to enrollment
Principal Investigator: Adam Hebb, MD
Research Coordinator: Joshua Nedrud (303.812.6422)


RESPECT: Dabigatran Etexilate for Secondary Stroke Prevention in Patients With Embolic Stroke of Undetermined Source 

This study is examining whether Pradaxa, an oral anticoagulant, is superior to aspirin in preventing strokes in patients with embolic stroke of undetermined source.

eligibility and information – Closed to enrollment
Principal Investigator: Jeffery Wagner, MD


Inpatient

POINT: Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke 

This study examines whether the combination of low-dose aspirin and clopidogrel increases the effectiveness in reducing the risk of stroke, heart attacks and other complications in patients who have just had a transient ischemic attack or a minor stroke. The study will also compare the risks of the combination with the risks from aspirin alone.

eligibility and information – Closed to enrollment
Principal Investigator: Ira Chang, MD

 

Colorado Neurological Insitute